It is my understanding that the company, Sequiam, has plenty of space in China. I do believe that a joint venture and acquisition has provided the company with a manufacturing-research facility. I could be wrong on this as I am just now delving into this one. Any help on this issue would be appreciated.
Loanstew: I agree on watching the share count thru the Transfer agent. That is the best way to judge dilution and Sequiam's transfer agent provides up to date info concerning the outstanding shares.
It is public knowledge and was made very public during April 2007 that Biometric Investors received 65 million warrants for taking the role of financier and committing to a $11.5 million credit facility.
Much progress has been made over the past 4 months. Hopefully now that the control issue has been resolved we can again concentrate on the fundamental improvement of the company.
Issuing warrants versus issuing shares of common stock? Is it necessary that we take the time to educate someone on the difference between issuing a warrant and issuing shares of common stock? I find no evidence that new shares have been issued or have been calculated in Sequiam's outstanding shares at the present time.
Until the outstanding shares of Sequiam increases by 65 million this is a non issue at the current time. It is something to keep in mind but not an issue until the warrants convert.